Yes, lifestyle changes like diet and exercise can influence GLP-1 levels and improve insulin sensitivity and overall metabolic health
Traveling for Treatment
Sometimes it is caused by a serious heart problem, and other times it is not
Ongoing drug trials are seeking to demonstrate, in the next several years, if GLP-1 drugs are effective at treating and/or reducing rates of obstructive sleep apnea, heart failure, NASH (nonalcoholic steatohepatitis) and MASH (metabolic dysfunction-associated steatohepatitis), chronic kidney disease, peripheral arterial disease, joint replacement, osteoarthritis, Alzheimers, cancer and all-cause mortality
NMN has fewer practical hurdles for daily use in terms of cost, availability, and ease of use